Expression of M30 and M65 in celiac disease. Analytical cross-sectional study

Detalhes bibliográficos
Autor(a) principal: Aksoy,Evrim Kahramanoğlu
Data de Publicação: 2018
Outros Autores: Şimşek,Gülçin Güler, Torgutalp,Murat, Sapmaz,Ferdane Pirinççi, Akpınar,Muhammet Yener, Uzman,Metin, Nazlıgül,Yaşar
Tipo de documento: Artigo
Idioma: eng
Título da fonte: São Paulo medical journal (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802018000600525
Resumo: ABSTRACT BACKGROUND: The role of villous atrophy in apoptosis, a distinctive feature of celiac disease, is a matter of controversy. The aim of this study was to determine the apoptosis rate through immunohistochemical staining for M30 and M65 in celiac disease cases. DESIGN AND SETTING: Analytical cross-sectional study in a tertiary-level center. METHODS: Duodenal biopsies from 28 treatment-naive patients with celiac disease, 16 patients with potential celiac disease, 10 patients with a gluten-free diet and 8 controls were subjected to immunohistochemical staining for the end-apoptotic marker M30 and the total cell death marker M65. H-scores were compared. Several laboratory parameters were recorded concomitantly, and at the one-year follow-up for celiac disease and potential celiac disease patients. RESULTS: There was a significant difference in H-score for M30 expression between the celiac disease, potential celiac disease and gluten-free diet groups (P = 0.009). There was no significant difference in H-score for M65 expression. There was a positive correlation between the H-score for M30 expression and the anti-tissue transglutaminase immunoglobulin A (anti-tTgIgA) and anti-tissue transglutaminase immunoglobulin G (anti-tTgIgG) levels (R = 0.285, P = 0.036; and R = 0.307, P = 0.024, respectively); and between the H-score for M65 expression and the anti-tTgIgA and anti-tTgIgG levels (R = 0.265, P = 0.053; and R=0.314, P = 0.021, respectively). There was no difference between celiac disease and potential celiac disease patients regarding the laboratory parameters selected. CONCLUSION: The rates of apoptosis and nutritional deficiencies in patients with potential celiac disease were similar to those in patients with celiac disease.
id APM-1_a9f6c53d0545b4d80e62825e439cb809
oai_identifier_str oai:scielo:S1516-31802018000600525
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling Expression of M30 and M65 in celiac disease. Analytical cross-sectional studyCeliac diseaseM30 cytokeratin-18 peptide, humanM65 antigen, humanABSTRACT BACKGROUND: The role of villous atrophy in apoptosis, a distinctive feature of celiac disease, is a matter of controversy. The aim of this study was to determine the apoptosis rate through immunohistochemical staining for M30 and M65 in celiac disease cases. DESIGN AND SETTING: Analytical cross-sectional study in a tertiary-level center. METHODS: Duodenal biopsies from 28 treatment-naive patients with celiac disease, 16 patients with potential celiac disease, 10 patients with a gluten-free diet and 8 controls were subjected to immunohistochemical staining for the end-apoptotic marker M30 and the total cell death marker M65. H-scores were compared. Several laboratory parameters were recorded concomitantly, and at the one-year follow-up for celiac disease and potential celiac disease patients. RESULTS: There was a significant difference in H-score for M30 expression between the celiac disease, potential celiac disease and gluten-free diet groups (P = 0.009). There was no significant difference in H-score for M65 expression. There was a positive correlation between the H-score for M30 expression and the anti-tissue transglutaminase immunoglobulin A (anti-tTgIgA) and anti-tissue transglutaminase immunoglobulin G (anti-tTgIgG) levels (R = 0.285, P = 0.036; and R = 0.307, P = 0.024, respectively); and between the H-score for M65 expression and the anti-tTgIgA and anti-tTgIgG levels (R = 0.265, P = 0.053; and R=0.314, P = 0.021, respectively). There was no difference between celiac disease and potential celiac disease patients regarding the laboratory parameters selected. CONCLUSION: The rates of apoptosis and nutritional deficiencies in patients with potential celiac disease were similar to those in patients with celiac disease.Associação Paulista de Medicina - APM2018-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802018000600525Sao Paulo Medical Journal v.136 n.6 2018reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APM10.1590/1516-3180.2018.0241161118info:eu-repo/semantics/openAccessAksoy,Evrim KahramanoğluŞimşek,Gülçin GülerTorgutalp,MuratSapmaz,Ferdane PirinççiAkpınar,Muhammet YenerUzman,MetinNazlıgül,Yaşareng2019-03-14T00:00:00Zoai:scielo:S1516-31802018000600525Revistahttp://www.scielo.br/spmjhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2019-03-14T00:00São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
title Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
spellingShingle Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
Aksoy,Evrim Kahramanoğlu
Celiac disease
M30 cytokeratin-18 peptide, human
M65 antigen, human
title_short Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
title_full Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
title_fullStr Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
title_full_unstemmed Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
title_sort Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
author Aksoy,Evrim Kahramanoğlu
author_facet Aksoy,Evrim Kahramanoğlu
Şimşek,Gülçin Güler
Torgutalp,Murat
Sapmaz,Ferdane Pirinççi
Akpınar,Muhammet Yener
Uzman,Metin
Nazlıgül,Yaşar
author_role author
author2 Şimşek,Gülçin Güler
Torgutalp,Murat
Sapmaz,Ferdane Pirinççi
Akpınar,Muhammet Yener
Uzman,Metin
Nazlıgül,Yaşar
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Aksoy,Evrim Kahramanoğlu
Şimşek,Gülçin Güler
Torgutalp,Murat
Sapmaz,Ferdane Pirinççi
Akpınar,Muhammet Yener
Uzman,Metin
Nazlıgül,Yaşar
dc.subject.por.fl_str_mv Celiac disease
M30 cytokeratin-18 peptide, human
M65 antigen, human
topic Celiac disease
M30 cytokeratin-18 peptide, human
M65 antigen, human
description ABSTRACT BACKGROUND: The role of villous atrophy in apoptosis, a distinctive feature of celiac disease, is a matter of controversy. The aim of this study was to determine the apoptosis rate through immunohistochemical staining for M30 and M65 in celiac disease cases. DESIGN AND SETTING: Analytical cross-sectional study in a tertiary-level center. METHODS: Duodenal biopsies from 28 treatment-naive patients with celiac disease, 16 patients with potential celiac disease, 10 patients with a gluten-free diet and 8 controls were subjected to immunohistochemical staining for the end-apoptotic marker M30 and the total cell death marker M65. H-scores were compared. Several laboratory parameters were recorded concomitantly, and at the one-year follow-up for celiac disease and potential celiac disease patients. RESULTS: There was a significant difference in H-score for M30 expression between the celiac disease, potential celiac disease and gluten-free diet groups (P = 0.009). There was no significant difference in H-score for M65 expression. There was a positive correlation between the H-score for M30 expression and the anti-tissue transglutaminase immunoglobulin A (anti-tTgIgA) and anti-tissue transglutaminase immunoglobulin G (anti-tTgIgG) levels (R = 0.285, P = 0.036; and R = 0.307, P = 0.024, respectively); and between the H-score for M65 expression and the anti-tTgIgA and anti-tTgIgG levels (R = 0.265, P = 0.053; and R=0.314, P = 0.021, respectively). There was no difference between celiac disease and potential celiac disease patients regarding the laboratory parameters selected. CONCLUSION: The rates of apoptosis and nutritional deficiencies in patients with potential celiac disease were similar to those in patients with celiac disease.
publishDate 2018
dc.date.none.fl_str_mv 2018-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802018000600525
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802018000600525
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1516-3180.2018.0241161118
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Paulista de Medicina - APM
publisher.none.fl_str_mv Associação Paulista de Medicina - APM
dc.source.none.fl_str_mv Sao Paulo Medical Journal v.136 n.6 2018
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1754209266235867136